TENAX THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tenax Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2023.
  • Tenax Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$180K -100% Dec 31, 2023 10-K 2024-03-28
Q3 2023 $0 -$207K -100% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $0 -$235K -100% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $0 -$261K -100% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $180K -$108K -37.6% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $207K -$106K -33.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $235K -$104K -30.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $261K +$232K +781% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $288K +$229K +389% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $313K +$226K +259% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $339K +$223K +194% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $29.7K -$113K -79.2% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $58.8K -$111K -65.3% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $87.3K -$108K -55.4% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $115K -$106K -48% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $143K -$104K -42.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $169K +$169K Dec 31, 2019 10-K/A 2021-04-16
Q3 2019 $196K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $222K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $247K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.